关注
Ivonne Suridjan
Ivonne Suridjan
University of Toronto, Abbvie Inc
在 abbvie.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes
E Setiawan, AA Wilson, R Mizrahi, PM Rusjan, L Miler, G Rajkowska, ...
JAMA psychiatry 72 (3), 268-275, 2015
8682015
Increased stress-induced dopamine release in psychosis
R Mizrahi, J Addington, PM Rusjan, I Suridjan, A Ng, I Boileau, ...
Biological psychiatry 71 (6), 561-567, 2012
3112012
Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum
AL Benedet, M Milà-Alomà, A Vrillon, NJ Ashton, TA Pascoal, F Lussier, ...
JAMA neurology 78 (12), 1471-1483, 2021
2472021
Imaging Neuroinflammation in Gray and White Matter in Schizophrenia: An In-Vivo PET Study With [ 18 F]-FEPPA
M Kenk, T Selvanathan, N Rao, I Suridjan, P Rusjan, G Remington, ...
Schizophrenia bulletin 41 (1), 85-93, 2015
1862015
Translocator Protein (18 kDa) Polymorphism (rs6971) Explains in-vivo Brain Binding Affinity of the PET Radioligand [18F]-FEPPA
R Mizrahi, PM Rusjan, J Kennedy, B Pollock, B Mulsant, I Suridjan, ...
Journal of Cerebral Blood Flow & Metabolism 32 (6), 968-972, 2012
1612012
Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [18F]FEPPA
S Hafizi, HH Tseng, N Rao, T Selvanathan, M Kenk, RP Bazinet, ...
American Journal of Psychiatry 174 (2), 118-124, 2017
1372017
Synaptic changes in Parkinson disease assessed with in vivo imaging
D Matuskey, S Tinaz, KC Wilcox, M Naganawa, T Toyonaga, M Dias, ...
Annals of neurology 87 (3), 329-338, 2020
1352020
In-vivo imaging of grey and white matter neuroinflammation in Alzheimer’s disease: a positron emission tomography study with a novel radioligand,[18F]-FEPPA
I Suridjan, BG Pollock, N Verhoeff, AN Voineskos, T Chow, PM Rusjan, ...
Molecular psychiatry 20 (12), 1579-1587, 2015
1242015
Stress-induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis use
R Mizrahi, M Kenk, I Suridjan, I Boileau, TP George, K McKenzie, ...
Neuropsychopharmacology 39 (6), 1479-1489, 2014
992014
Effects of antipsychotics on D3 receptors: a clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO
R Mizrahi, O Agid, C Borlido, I Suridjan, P Rusjan, S Houle, G Remington, ...
Schizophrenia research 131 (1-3), 63-68, 2011
882011
Elevated striatal dopamine function in immigrants and their children: a risk mechanism for psychosis
A Egerton, OD Howes, S Houle, K McKenzie, LR Valmaggia, MR Bagby, ...
Schizophrenia bulletin 43 (2), 293-301, 2017
842017
Neuroinflammation in healthy aging: A PET study using a novel Translocator Protein 18 kDa (TSPO) radioligand,[18F]-FEPPA
I Suridjan, PM Rusjan, AN Voineskos, T Selvanathan, E Setiawan, ...
Neuroimage 84, 868-875, 2014
752014
An accurate fully automated panel of plasma biomarkers for Alzheimer's disease
S Palmqvist, E Stomrud, N Cullen, S Janelidze, E Manuilova, A Jethwa, ...
Alzheimer's & Dementia 19 (4), 1204-1215, 2023
652023
Dopamine response to psychosocial stress in chronic cannabis users: a PET study with [11C]-(+)-PHNO
R Mizrahi, I Suridjan, M Kenk, TP George, A Wilson, S Houle, P Rusjan
Neuropsychopharmacology 38 (4), 673-682, 2013
602013
CSF synaptic biomarkers in the preclinical stage of Alzheimer disease and their association with MRI and PET: a cross-sectional study
M Milà-Alomà, A Brinkmalm, NJ Ashton, H Kvartsberg, M Shekari, ...
Neurology 97 (21), e2065-e2078, 2021
492021
Dopamine response to psychosocial stress in humans and its relationship to individual differences in personality traits
I Suridjan, I Boileau, M Bagby, PM Rusjan, AA Wilson, S Houle, R Mizrahi
Journal of psychiatric research 46 (7), 890-897, 2012
422012
Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task
I Suridjan, P Rusjan, J Addington, AA Wilson, S Houle, R Mizrahi
Journal of Psychiatry and Neuroscience 38 (2), 98-106, 2013
392013
The application of positron emission tomography (PET) imaging in CNS drug development
I Suridjan, RA Comley, EA Rabiner
Brain imaging and behavior 13, 354-365, 2019
372019
Test‐retest variability of plasma biomarkers in Alzheimer's disease and its effects on clinical prediction models
NC Cullen, S Janelidze, N Mattsson‐Carlgren, S Palmqvist, T Bittner, ...
Alzheimer's & Dementia 19 (3), 797-806, 2023
342023
Nigral stress-induced dopamine release in clinical high risk and antipsychotic-naïve schizophrenia
HH Tseng, JJ Watts, M Kiang, I Suridjan, AA Wilson, S Houle, PM Rusjan, ...
Schizophrenia bulletin 44 (3), 542-551, 2018
342018
系统目前无法执行此操作,请稍后再试。
文章 1–20